130 related articles for article (PubMed ID: 25968877)
1. Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysis.
Yuan B; Zhao H; Xue X; Zhou J; Wang X; Han Y; Zhang L; Guo X; Zhi Q
Anticancer Agents Med Chem; 2016; 16(4):407-13. PubMed ID: 25968877
[TBL] [Abstract][Full Text] [Related]
2. Expression of B-cell-specific Moloney murine leukemia virus integration site 1 mRNA and protein in gastric cancer.
Liu PW; Lin Y; Chen XY
J Dig Dis; 2014 Apr; 15(4):166-73. PubMed ID: 24393364
[TBL] [Abstract][Full Text] [Related]
3. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of polycomb group protein B-cell-specific moloney murine leukemia virus insertion site 1 in stage II colon cancer patients.
Espersen ML; Linnemann D; Christensen IJ; Alamili M; Troelsen JT; Høgdall E
APMIS; 2016 Jul; 124(7):541-6. PubMed ID: 27102362
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
6. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z
BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552
[TBL] [Abstract][Full Text] [Related]
7. Lgr5 Contributes to Intestinal Metaplasia During Gastric Carcinogenesis: A Meta analysis.
Han Y; Zhi Q; Xue X; Yuan B; Zhao H; Kuang Y; Zhang L
Anticancer Agents Med Chem; 2016; 16(9):1079-84. PubMed ID: 26077638
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of CD44 expression in gastric cancer: a meta-analysis.
Chen Y; Fu Z; Xu S; Xu Y; Xu P
Biomed Pharmacother; 2014 Jul; 68(6):693-7. PubMed ID: 25194445
[TBL] [Abstract][Full Text] [Related]
10. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.
He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A
Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924
[TBL] [Abstract][Full Text] [Related]
11. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Dickkopf-1 in Gastric Cancer Survival: A Meta-Analysis.
Liu QR; Li YF; Deng ZQ; Cao JQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):170-5. PubMed ID: 27023747
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
16. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.
Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K
Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514
[TBL] [Abstract][Full Text] [Related]
17. Vimentin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis.
Yin S; Chen FF; Yang GF
Pathol Res Pract; 2018 Sep; 214(9):1376-1380. PubMed ID: 30078472
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.
Ha SY; Kim SH
Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]